Article
Effects of pharmacogenomic (PGx) testing on clinical pain management prescriptions, a retrospective study
2021-06-28
Abstract excerpt
Current deficits in effectively utilizing PGx testing in clinical practice include limited awareness and training of healthcare professionals, routine ordering of assays investigating up to 5 genes and lack of concise reporting of dosing guidelines and drug-drug-interactions. A novel deep sequencing (>1000X) PGx panel is described encompassing 23 genes and 141 SNPs or indels combined with PGx dosing guidance, drug...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0e51db9-3bd4-5213-892e-c637d9aed13f
- DOI
- 10.1101/2021.06.21.21258931